Zobrazeno 1 - 10
of 1 233
pro vyhledávání: '"Cuffel, B."'
Autor:
Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Symptom Assessment Systems, 1416 Marconi St, Houston, TX, USA., Keating KN; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Cuffel B; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Elbi C; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Siegel JM; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA., Gerlinger C; Bayer AG, Berlin, Germany.; Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, Homburg/Saar, Germany., Symonds T; Clinical Outcomes Solutions, Folkestone, Kent, UK., Sloan JA; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Dueck AC; Section of Biostatistics, Division of Health Sciences Research, Mayo Clinic, Phoenix, AZ, USA., Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Bottomley Consulting Group, Brussels, Belgium., Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams LA; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. tito.mendoza@nih.gov.; National Cancer Institute Office of Patient-Centered Outcomes, National Institutes of Health, Bethesda, MD, 20814, USA. tito.mendoza@nih.gov.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 27; Vol. 14 (1), pp. 14839. Date of Electronic Publication: 2024 Jun 27.
Autor:
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Cuffel B; Bayer Pharmaceuticals, Basel, Switzerland., Paracha N; Bayer Pharmaceuticals, Basel, Switzerland., Vail E; Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA., Garcia-Foncillas J; University Cancer Institute and the Department of Oncology, University Hospital Fundacion Jimenez Diaz, Madrid, Spain., Goodman C; The Lewin Group, Inc., Falls Church, VA, USA., Lassen U; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vassal G; Gustave Roussy Comprehensive Cancer Center, Villejuif, France., Sullivan SD; CHOICE Institute, Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA.
Publikováno v:
The oncologist [Oncologist] 2023 May 08; Vol. 28 (5), pp. e242-e253.
Autor:
Cramer, J. A.1 joyce.cramer@yale.edu, Cuffel, B. J.2, Divan, V.3, Al-Sabbagh, A.4, Glassman, M.5
Publikováno v:
Acta Neurologica Scandinavica. Mar2006, Vol. 113 Issue 3, p156-162. 7p. 3 Charts.
Autor:
Pollack M; Xcenda, L.L.C, Palm Harbor, FL, USA., Keating K; Bayer Healthcare Pharmaceuticals Inc, Whippany, NJ, USA., Wissinger E; Xcenda, L.L.C, Palm Harbor, FL, USA., Jackson L; Bayer Healthcare Pharmaceuticals Inc, Whippany, NJ, USA., Sarnes E; Xcenda, L.L.C, Palm Harbor, FL, USA., Cuffel B; Bayer Healthcare Pharmaceuticals Inc, Whippany, NJ, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2021 Jan; Vol. 37 (1), pp. 59-70. Date of Electronic Publication: 2020 Nov 28.
Autor:
Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA. tmendoza@mdanderson.org., Williams LA; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA., Keating KN; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Siegel J; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Elbi C; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Nowak AK; Faculty of Health and Medical Sciences, UWA Medical School, The University of Western Australia, 35 Stirling Highway, Perth, WA, 6009, Australia., Hassan R; Thoracic and Gastrointestinal Malignancies Branch, NCI/CCR, 10 Center Drive, Bethesda, MD, 20892, USA., Cuffel B; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2019 Jun 17; Vol. 3 (1), pp. 34. Date of Electronic Publication: 2019 Jun 17.
Publikováno v:
Journal of managed care pharmacy : JMCP. 14(5)
BACKGROUND: Sustained treatment with a cholinesterase inhibitor (ChEI) is used in the management of the symptoms of Alzheimer’s disease (AD). However, the characteristic declines in learning and memory seen in AD may erode the patient’s ability t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0ef4c39447f3345e2c96394589657a
https://pubmed.ncbi.nlm.nih.gov/18597575
https://pubmed.ncbi.nlm.nih.gov/18597575
Autor:
Williams LA; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA. loriwilliams@mdanderson.org., Whisenant MS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA., Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA., Haq S; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA., Keating KN; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Cuffel B; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany, NJ, 07981, USA., Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2018 Dec; Vol. 27 (12), pp. 3229-3241. Date of Electronic Publication: 2018 Sep 05.
Autor:
Cuffel B
Publikováno v:
Psychiatric services (Washington, D.C.). 48(12)
Efforts to increase the cost-effectiveness of public mental health systems are hindered by inadequate information about the determinants of use and cost. This paper reviews empirical research and theory suggesting that costs in the public health syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc938dbe5348c8baa9a3280886a7d296
https://pubmed.ncbi.nlm.nih.gov/9406264
https://pubmed.ncbi.nlm.nih.gov/9406264
Publikováno v:
In European Journal of Cancer September 2015 51 Supplement 3:S64-S64
Autor:
Bourgeau, Melanie1, Gardner, Jerad M.2
Publikováno v:
Archives of Pathology & Laboratory Medicine. Mar2024, Vol. 148 Issue 3, p284-291. 8p.